Reply to Mengxin Lu, Yi Zhang, Yu Xiao's Letter to the Editor, re: Kimmo Kettunen, Peter J. Boström, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430-4
Eur Urol. 2019 Nov;76(5):e137-e138.
doi: 10.1016/j.eururo.2019.07.049.
Epub 2019 Aug 13.
1 Institute of Biomedicine, University of Turku, and Department of Pathology, Turku University Hospital, Turku, Finland.
2 Department of Urology, Turku University Hospital and University of Turku, Turku, Finland.
3 Institute of Biomedicine, University of Turku, and Department of Pathology, Turku University Hospital, Turku, Finland. Electronic address: pekka.taimen@utu.fi.